HKEX:1113 stock news
This page provides real-time market news, earnings updates, and company announcements related to CK Asset Holdings Limited (HKEX:1113).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-07-12 01:44 HKT
Hong Kong Stocks Midday Review: First Trading Day of 2026 Opens Strong, Hang Seng Index Closes Up 2.18%
美港电讯2026-01-02 04:09:30

Cronos Launches New All-in-One Vape, Spinach PUFFERZ
Finviz2026-02-17 12:33:44

Immuron Reports HY26 Results and Strategic Reset
Finviz2026-02-25 11:03:09

Lantronix Advances Platform Scaling Strategy With MediaTek-Based Embedded Compute Expansion
Finviz2026-03-05 12:03:11

Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
Finviz2026-03-11 17:04:02

Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
Finviz2026-03-11 17:04:02

BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9
Finviz2026-03-11 18:06:59

Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline
Finviz2026-03-18 12:33:43

Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-18 12:33:43

Cisco Reimagines Security for the Agentic Workforce
Finviz2026-03-23 12:03:49

U.S. GOLD CORP. TO PARTICIPATE IN THE LYTHAM PARTNERS 2026 INDUSTRIALS & BASIC MATERIALS INVESTOR SUMMIT ON APRIL 1, 2026
Finviz2026-03-25 12:03:56

Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
Finviz2026-03-11 17:04:02

Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
Finviz2026-03-11 17:04:02

BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9
Finviz2026-03-11 18:06:59

Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline
Finviz2026-03-18 12:33:43

Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-18 12:33:43

Cisco Reimagines Security for the Agentic Workforce
Finviz2026-03-23 12:03:49

U.S. GOLD CORP. TO PARTICIPATE IN THE LYTHAM PARTNERS 2026 INDUSTRIALS & BASIC MATERIALS INVESTOR SUMMIT ON APRIL 1, 2026
Finviz2026-03-25 12:03:56
HKEX:1113 stock price change
On the last trading day, HKEX:1113 stock closed at 45.46 HKD, with a price change of 1.56% for the day.
Trade spot stocks (24/7)Trade stock perps (up to 100x leverage)HKEX:1113 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn more